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The A-kinase-anchoring protein 5 (AKAP5), a post-synaptic multi-adaptor molecule that
binds G-protein-coupled receptors and intracellular signaling molecules has been impli-
cated in emotional processing in rodents, but its role in human emotion and behavior is up
to now still not quite clear. Here,we report an association of individual differences in aggres-
sive behavior and anger expression with a functional genetic polymorphism (Pro100Leu)
in the human AKAP5 gene. Among a cohort of 527 young, healthy individuals, carriers
of the less common Leu allele (15.6% allele frequency) scored signiﬁcantly lower in the
physical aggression domain of the Buss and Perry Aggression Questionnaire and higher
in the anger control dimension of the state-trait anger expression inventory. In a func-
tional magnetic resonance imaging experiment we could further demonstrate that AKAP5
Pro100Leumodulates the interaction of negative emotional processing and executive func-
tions. In order to investigate implicit processes of anger control, we used the well-known
ﬂanker task to evoke processes of action monitoring and error processing and added task-
irrelevant neutral or angry faces in the background of the ﬂanker stimuli. In line with our
predictions, Leu carriers showed increased activation of the anterior cingulate cortex (ACC)
during emotional interference, which in turn predicted shorter reaction times and might be
related to stronger control of emotional interference. Conversely, Pro homozygotes exhib-
ited increased orbitofrontal cortex (OFC) activation during emotional interference, with no
behavioral advantage. Immunohistochemistry revealed AKAP5 expression in post mortem
human ACC and OFC. Our results suggest that AKAP5 Pro100Leu contributes to individ-
ual differences in human aggression and anger control. Further research is warranted to
explore the detailed role of AKAP5 and its gene product in human emotion processing.
Keywords: AKAP5, genetic, aggression, anger, fMRI
INTRODUCTION
Human aggression shows considerable interindividual variability.
Signiﬁcant contributions to aggression originate in the emotion
of anger, which itself shows high variability within the popula-
tion (Berkowitz and Harmon-Jones, 2004). Several studies suggest
that aggressive behavior is related to interactions of environ-
mental factors like aversive childhood experience or substance-
related disorders with genetic variations in monoaminergic neu-
romodulatory systems, speciﬁcally dopaminergic, noradrenergic,
and serotonergic neurotransmission, might inﬂuence aggressive
behavior (Caspi et al., 2002; Panksepp, 2006; Kang et al., 2008;
Kulikova et al., 2008; Heinz et al., 2011). Functional neuroimaging
studies have demonstrated that genetic variants linked to aggres-
sion and anger are associated with altered neuronal activation
patterns during emotional processing (Meyer-Lindenberg et al.,
2006; Buckholtz and Meyer-Lindenberg, 2008). Up to now, genetic
studies on anger and aggression have focused on variants directly
related to these transmitter systems, like receptors or metabolizing
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enzymes (Buckholtz and Meyer-Lindenberg, 2008; Kang et al.,
2008; Kulikova et al., 2008; Hess et al., 2009). G-protein-coupled
receptor (GPCR) activation by monoamines, however, triggers
complex intracellular signaling cascades that exert relatively long-
lasting inﬂuences on neuronal processing. Thus the question arises
whether genetic heterogeneity in these signaling cascades might
also inﬂuence interindividual variability in human anger and
aggression. Initial evidence from depressed patients suggests that
the transcription factor CREB, which is activated by GPCR signal-
ing, shows genetic variations that affect human anger expression
(Perlis et al., 2007), but the inﬂuence of genetic variations in intra-
cellular signaling molecules on anger and aggression in the healthy
population remains thus far unclear.
The A-kinase-anchoring proteins (AKAPs) are a family of pro-
teins that bind the cAMP-dependent protein kinase A (PKA), a
major effector enzymeof numerousGPCRs.AKAPs are involved in
the subcellular targeting of receptor-activated protein kinases and
phosphatases and are likely to play a crucial role in the coordina-
tion of GPCR-mediated signaling (Carnegie et al., 2009). AKAP5
(AKAP79/150) is a multi-adaptor molecule that binds GPCRs,
particularly beta-adrenergic receptors (Fraser et al., 2000; Gard-
ner et al., 2007), protein kinases A and C, protein phosphatase 2B,
and MAGuK-type post-synaptic adaptor molecules (Dell’Acqua
et al., 2006; Figure 1A).
In striatal and prefrontal cortex neurons, where precise com-
munication between glutamatergic and dopaminergic systems is
crucial to neural processes underlying cognitive control, emotion,
and reward, the AKAP5 gene product was shown to be critically
involved in this crosstalk between D1 receptor-dependent neu-
romodulation and AMPA receptor-mediated synaptic plasticity
(Swayze et al., 2004). Animal research has provided converging
evidence for a role of AKAP5 in the neural processing of (negative)
emotions. In rodents, inhibition of the corresponding protein
AKAP150 has been associated with impaired consolidation of fear
learning (Moita et al., 2002), speciﬁcally with reduced consoli-
dation and enhanced extinction of fear memories (Nijholt et al.,
2008). Disruption of AKAP5 in mice has been associated with
physiological and behavioral abnormalities, including deﬁcits in
long-term depression (LTD) and memory retention (Tunquist
et al., 2008).
So far, the impact of genetic variations in AKAP5 on human
behavior is yet unclear. In thehumanAKAP5gene (Chr 14q21–24),
a functional genetic polymorphism leads to a substitution of pro-
line to leucine at position 100 of the protein (AKAP5 Pro100Leu;
dbSNP rs2230491). Protein structure prediction suggests that this
amino acid substitution might inﬂuence protein folding and cur-
vature (Figure 1B) Based on cell-biological ﬁndings and animal
experiments about AKAP function as a key synchronizer of neu-
ronal events (Tunquist et al., 2008) and its association with GPCR
signaling,we therefore hypothesized that the polymorphismmight
inﬂuence human aggression as well as aggression-related emo-
tions and their control. Previous expression studies of the human
AKAP5 gene product (AKAP79) showed a high abundance in
several CNS regions relevant for emotional and motivational
processes, including the amygdala, the hippocampus and the stria-
tum (Sik et al., 2000; Ulﬁg et al., 2001, 2003), also pointing to a
role of AKAP5 in human emotional processing.
We investigated the effects of AKAP5 Pro100Leu on human
aggressive behavior and anger expression in young, healthy par-
ticipants by using well-established questionnaires of anger and
aggression (Buss and Perry, 1992; State Trait Anger Expression
Inventory; Spielberger, 1991). Based on the questionnaire data,
FIGURE 1 | (A) Structure of the human AKAP5 protein with the
Pro100Leu polymorphism. A, B, C, basic membrane association domains;
PP2B, protein phosphatase 2B binding site; PKA, protein kinase A binding
site; GPCR, G-protein-coupled receptor binding region; MAGuK, binding
region for membrane-associated guanylate kinase proteins. (B) Protein
structure prediction using PEP-FOLD software suggests that AKAP5
Pro100Leu substitution leads to extension of an α-helical region (depicted
as red cylinder), with potential consequences on the folding of domains
located downstream of the mutation. (C) Genotyping of the AKAP5
Pro100Leu polymorphism. AluI digestion of the PCR products results in
two fragments (174+98bp) for the Leu allele or a single fragment
(272 bp) for the Pro allele. PP, Pro/Pro; PL, Pro/Leu; LL, Leu/Leu; M, DNA
size marker. (D) Gender bias in the distribution of the AKAP5 Pro100Leu
polymorphism. Bar plots depict percentages of Pro/Pro (P/P), Pro/Leu
(P/L), and Leu/Leu (L/L) carriers, separated by gender. The Leu allele was
signiﬁcantly more prevalent among women.
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which revealed signiﬁcantly lower physical aggression and signiﬁ-
cantly higher anger-control behavior in carriers of the more rare
Leu allele, we developed a functional magnetic resonance imag-
ing (fMRI) study to investigate the neurobiological processes that
may underlie these behavioral effects. Because Leu carriers exhib-
ited stronger anger control, we aimed to integrate anger-related
stimuli in a demanding cognitive task.
Several studies of emotional conﬂict regulation haved use an
“emotional Stroop” task (see Etkin et al., 2006; Haas et al., 2006;
Egner et al., 2008) and discussed the important role of rostral
and caudal anterior cingulate cortex (ACC) in the processing of
incompatible emotional dimensions. The cited emotional Stroop
tasks have used compatible and incompatible combinations of
emotional words and emotional faces in order to create congruent
and incongruent trials and to provoke “real” emotional conﬂicts
in incongruent conditions. In another version of the emotional
Stroop task, subjects are asked to identify the ink color of neutral
vs. emotionally salient words. The slower reaction times (RTs) for
emotionally salient words have been suggested to reﬂect emotional
interference (Etkin et al., 2006). Concerning the speciﬁc emotion
of anger, Van Honk et al. (2001) demonstrated that individuals
scoring high on trait–anger exhibited an attentional bias toward
angry faces. In addition to Stroop tasks, variants of the Flanker task
(Eriksen and Eriksen, 1974) have also been used to investigate the
interaction of emotional and cognitive processes. Neuroimaging
studies of classical Flanker tasks typically discuss the role of the
dorsal anterior cingulate cortex (dACC) in conﬂict processing dur-
ing incongruent trials (Kerns et al., 2004;Mansouri et al., 2009). In
emotional variants of this paradigm, when neutral vs. emotional
faces were used as target stimuli (Fenske and Eastwood, 2003;
Horstmann et al., 2006), prolonged RTs have been observed for
the processing of negative emotional stimuli. It should be noted,
though, that in all these tasks, processing of the emotional stimuli
was directly relevant for task performance.
An alternative approach was used in an ERP-Study by Wiswede
et al. (2009), where pictures from the International Affective Pic-
ture System (IAPS) served as task-irrelevant distracters during a
ﬂanker paradigm. A stronger increase of the error-related negativ-
ity (ERN) was observed for errors in trials with negative emotional
distraction (Wiswede et al., 2009). It should be noted though, that
no neuroimaging study so far has used a comparable paradigm
(i.e., emotional task-irrelevant distracters in the background of
ﬂanker stimuli) with face stimuli.
Given our primary aim, to assess neural mechanisms under-
lying the genetically mediated individual differences in anger
control, we aimed to design a paradigm in which emotional stim-
uli were anger-related and interfered with task performance. To
this end, we designed a modiﬁed version of the task described by
Wiswede et al. (2009). Instead of IAPS pictures, facial emotional
distracters (neutral vs. angry) were displayed in the background of
the ﬂanker stimuli in order to assess, how carriers of the two alleles
might differ in their neural processing of interference of attention
and anger processing rather than processing of negative emo-
tions in general. We hypothesized that Leu carriers, who exhibit
stronger anger control, would show a higher ability to successfully
focus on the cognitive ﬂanker task while fading out the emo-
tional distracters. At a neural level, such a behavioral advantage
might be associated with increased ACC activation. Pro homozy-
gotes, in contrast, might react more intensely to the emotional
distracters, which might be reﬂected by weaker task performance
and neuronal activation in emotion-relevant prefrontal areas like
the orbitofrontal cortex (OFC).
Since the AKAP5 expression pattern in human cortical areas
implicated in the cognitive control of emotions, has not been
published so far, we also performed post mortem immunohisto-
chemistry in the frontolimbic cortical regions of interest (ROIs)
of our fMRI study.
MATERIALS AND METHODS
PARTICIPANTS
Five hundred ﬁfty-seven young (age range 18–36 years, mean
22.9± 3.1), healthy volunteers participated in the behavioral part
of our study. All participants had at least obtained university
entrance diploma or were enrolled at the Otto von Guericke Uni-
versity Magdeburg or at the Magdeburg-Stendal University of
Applied Sciences. The university entrance diploma was selected
as one of our criteria of inclusion in order to reach a compara-
ble educational background within our sample. Furthermore, the
participants were recruited from all departments of both univer-
sities like medicine, natural sciences, educational sciences, social
and health sciences, or economic sciences which ensured a certain
degree of variance in the sample. Moreover, students of psychol-
ogy were only allowed to take part in the study within their ﬁrst
academic year, to make sure, that they were as naïve as the other
participants to our questionnaires and tests. In addition to the
analyses of our data, a post hoc analysis of AKAP5 Pro100Leu
effects on Buss–Perry aggression questionnaire (BPAQ) scores was
performed in a cohort of 604 participants from the University
of Barcelona community (457 female, mean age 21.6± 3.1 years;
see Table 3). This cohort had been described in detail previously
(Krämer et al., 2007).
Seventy young, healthy German volunteers (35 Pro homozy-
gotes and Leu carriers, respectively) were recruited from our initial
cohort for participation in the fMRI study after exclusion of con-
traindications. Three of these participants had to be excluded due
to technical problems, leaving 67 participants for data analysis
(see Table 4 for detailed demographics). All participants gave
written informed consent in accordance with the Declaration of
Helsinki and received ﬁnancial compensation for participation.
The work was approved by the Ethics Committee of the University
of Magdeburg, Faculty of Medicine.
GENOTYPING
Genomic DNA was extracted from blood leukocytes using the
GenElute DNA extraction kit (Sigma Aldrich) according to the
manufacturer’s protocol. Genotyping was performed using PCR
followed by allele-speciﬁc restriction analysis. The DNA fragment
on Chr 14q21–24 containing the AKAP5 Pro100Leu polymor-
phism was ampliﬁed using the primers AKAP5_100-f (5′-GCT
TCT GAT CAG CCA GAG CCC AC-3′) and AKAP5_100-r (5′-
GCT TCT TCC TGG ACT TTG ATG CTG CAG-3′) and stan-
dard Taq polymerase (Qiagen and Fermentas). PCR products
were digested with AluI (Fermentas), yielding two fragments
(174+ 98 bp) for the Leu allele or a single fragment (272 bp) for
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the Pro allele. DNA fragments were separated on an ethidium
bromide-stained agarose gel and visualized under UV light (see
Figure 1C for genotyping example). All subjects suspected to be
homozygous for the less common Leu allele were genotyped twice.
The rater was blinded to the results of the personality inventories.
PCR products from two homozygous subjects (one P/P, one L/L)
were veriﬁed via custom sequencing (SeqLab), conﬁrming that
the PCR reaction had provided the desired DNA fragment on Chr
14q21–24.
To avoid population stratiﬁcation effects and to exclude
asymmetric distribution of other genetic variations that might
affect aggression or anger, participants were also genotyped for
the BDNF Val66Met polymorphism (Chr 11p13), the COMT
Val108/158Met polymorphism (Chr 22q11), the DRD2 TaqIA
polymorphism (Chr 11q23), the DRD3 Ser9Gly polymorphism
(Chr 3q13), the MAOA VNTR polymorphism (Chr Xp11),
the serotonin transporter fragment length polymorphism (Chr
17q11–12), for the serotonin receptor 5HT-2a His452Tyr poly-
morphism (Chr 13q14–21), and for additional polymorphisms
in pre- and post-synaptic adaptor proteins (detailed genotyping
protocols are available upon request), and X 2 tests were used
to compare the genotype distributions of these polymorphisms
between AKAP5 Pro homozygotes and Leu carriers.
QUESTIONNAIRE STUDY
Personality questionnaires
Participants completed two well-established questionnaires that
assess interindividual variability of aggression and anger. Self-
rating on aggressive behavior was assessed using the German
version of the BPAQ. The 29-item questionnaire (Buss and
Perry, 1992) assesses four factors of aggressive behavior: physical
aggression, verbal aggression, anger, and hostility.
The self-rating concerning the emotional state of anger
was surveyed with the state-trait anger expression inventory
(STAXI) developed by Spielberger (1991); German version by
Schwenkmezger and Hodapp, 1991). The STAXI contains ﬁve
anger-related subscales: the current level of anger (state anger),
anger as personality trait (tendency to experience anger, i.e., trait
anger); Anger-out behavior (AO; frequency with which anger is
expressed toward other people or objects); Anger-in behavior (AI;
directing anger toward oneself or inwardly; also related to sup-
pressed hostility);Anger-control behavior (AC; activemanagement
of feeling angry in order to avoid anger expression).
Statistical analysis
To examine the overall inﬂuence of AKAP5 on measures of aggres-
sive behavior and anger expression, we investigated the relation-
ship between AKAP5 genotype and the four domains of the BPAQ
(physical aggression, verbal aggression, anger, hostility) as well
as four out of ﬁve domains of the STAXI (trait anger, anger-in,
anger-out, anger control) as dependent variables. The state anger
dimension of the STAXI was not included, as this dimension is
deﬁned as a temporary emotional state and no stable quality of the
person. Therefore, possible genetic inﬂuences on the state measure
would most likely be disguised by considerable intra-individual
variability at any given time of testing. To circumvent the prob-
lem of multiple testing,we computed a single multivariate analysis
of variance (MANOVA) with the above mentioned test scores as
dependent variable and AKAP5 Pro100Leu (Pro homozygotes vs.
Pro/Leu and Leu/Leu) as independent variable of interest. Because
of the unequal distribution of the polymorphism in males and
females in our cohort (see below) and previous reports showing
higher aggression in males, we included gender as a further inde-
pendent variable. Age,which was slightly lower in Leu carriers (see
below),was included as a covariate of no interest. To ensure that all
data met the required assumptions for MANOVA,we ensured that
the sample size was large (N > 50 for all cells), and we computed
Levene’s test of variance homogeneity for all dependent variables.
Because variance homogeneity was not met for the dimension of
anger control (F3 = 5.858; p = 0.001),we adjusted the signiﬁcance
level for all post hoc tests to.025, as previously suggested for this
case (Tabachnick and Fidell, 1983).
Subscores with signiﬁcant effects of AKAP5 genotype in the
MANOVA were veriﬁed using one-tailed post hoc two-sample t -
tests, using a Bonferroni correction for multiple comparisons. To
further verify a possible speciﬁc inﬂuence of AKAP5 Pro100Leu on
certain BPAQ and STAXI subscores, a linear discriminant analysis
(LDA) was performed, into which all eight subscores were entered
in a stepwise fashion.
FUNCTIONAL MRI EXPERIMENT
Paradigm
Emotional stimuli have previously been demonstrated to interfere
with attentional processing, among others in the Eriksen ﬂanker
task (Fenske and Eastwood, 2003; Larson et al., 2006; Wiswede
et al., 2009). For instance,Wiswede et al. (2009) could demonstrate
that the presentation of unpleasant pictures from the International
Affective Picture System (IAPS) prior to each ﬂanker stimulus led
to an increased ERN compared to trials with neutral or pleasant
IAPS pictures.
The aim of the present study was to investigate the neural
mechanisms underlying the cognitive control of anger-related
emotional interference. Van Honk et al. (2001) had previously
demonstrated that attentional biases for angry faces are related
to trait anger. In relation to that observation and to our behav-
ioral ﬁnding of Leu carriers showing a higher anger control, we
hypothesized a genetically mediated performance advantage for
Leu carriers in an emotional ﬂanker task. Flanker stimuli, com-
prising a central target arrow pointing to the left or right side
and requiring a button press with the corresponding left or right
index ﬁnger were ﬂanked by irrelevant arrows either pointing in
the same (=congruent trials) or opposite (=incongruent trials)
direction. Flanker stimuli were superimposed on neutral or emo-
tional pictures (Van Honk et al., 2001; Larson et al., 2006;Wiswede
et al., 2009). According to the concept of embodying emotion
(Niedenthal, 2007) it is assumed that the perception of emotional
expressions evokes a re-experiencing of the speciﬁc emotion in
one’s self. Because we were particularly interested in anger con-
trol processing, faces with either neutral or angry expressions were
chosen as background stimuli. Face stimuli were obtained from the
Karolinska Directed Emotional Faces database (KDEF; Lundqvist
et al., 1998) and converted into black and white.
Figure 3A depicts the structure of an example trial. All tri-
als started with the presentation of a face (neutral or angry) for
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650ms, followed by a ﬂanker stimulus (congruent or incongruent)
for 200ms, during which the face stimulus was blurred, and the
presentation of the face stimulus for another 650ms. The inter-
trial interval was jittered near-exponentially between 2 and 8 s, to
optimize estimation of the trial-speciﬁc hemodynamic response
functions (HRFs; Hinrichs et al., 2000). To further improve our
estimation concerning the trial-speciﬁc HRFs, we included a base-
line condition in which the target stimulus was ﬂanked by neutral
stimuli (“-”) and presented with a blurred background face. The
experiment consisted of two runs, both comprising of 40 trials of
each condition (high vs. low interference× emotional vs. neutral;
baseline).
Image acquisition
Functional magnetic resonance imaging was performed using a
GE Signa 1.5 T magnetic resonance system (General Electric) and
a standard head coil. Two sessions of 428 echo-planar images
(EPIs) were acquired in an interleaved manner (23 axial slices;
voxel size= 3.13mm× 3.13mm× 4mm +1mm gap; TR= 2 s;
TE= 35ms; odd numbers ﬁrst). Additionally, a co-planar proton-
density (PD)-weighted MR image was acquired and used for
coregistration to improve spatial normalization.
Data processing and analysis
Statistical analyses were performed using Statistical Parametric
Mapping (SPM8,WellcomeDepartment of ImagingNeuroscience,
London, UK). EPIs were corrected for acquisition delay and head
motion. The co-planar PD-weighted image was coregistered to
the mean image obtained from motion correction and used as
reference image for spatial normalization to the Montreal Neu-
rological Institute (MNI) stereotactic coordinate system (voxel
size= 3mm× 3mm×3mm), the co-planar PD-weighted image
was used to determine normalization parameters.
Statistical analysis was carried out using a two-stage mixed
effects model. In the ﬁrst stage, the hemodynamic response was
modeled by convolving a delta function at stimulus onset with a
canonical HRF (Friston et al., 1998). The resulting time courses
were down sampled for each scan to form covariates of a general
linear model (GLM). The model included separate covariates for
each condition of interest (emotional incongruent, neutral incon-
gruent, emotional congruent, neutral congruent, baseline), the
six rigid-body movement parameters determined from realign-
ment as covariates of no interest, and a single constant repre-
senting the mean over scans. Model estimation was performed
using a restricted maximum likelihood ﬁt, and contrasts of para-
meter estimates were computed for the comparisons of inter-
est (emotional incongruent> neutral incongruent and emotional
congruent> neutral congruent).
In the second stage of the model, the conditions of interest
(emotional vs. neutral in the incongruent and congruent con-
dition, separated by genotype) were submitted to second level
random effects analyses. Speciﬁcally, planned t -test comparisons
were computed for the emotional interference contrasts in the
incongruent and congruent conditions, respectively, and masked
inclusively with the genotype by condition interaction F contrast
(thresholded at p< 0.05). Because of our strong a priori hypothe-
ses derived from the questionnaire data that AKAP5 genotype
would affect emotional interference processing in the anterior
cingulate (and adjacent dorsomedial PFC) and possibly in the
OFC, we focused our analyzes on ACC and OFC ROIs. ROIs were
deﬁned by Brodmann Areas (BAs 24, 32, and 6 for the ACC ROIs;
BA 11 for the OFC ROI) and extracted from the WFU PickAt-
las (Wake Forest University), and the signiﬁcance level was set
to p< 0.05, ROI–volume-corrected for family wise error (FWE).
Peak activationdifferences (SPMcontrasts of parameter estimates)
within these ROIs were submitted to conﬁdence interval esti-
mation using Bootstrap resampling and the percentile-t method
(Efron and Tibshirani, 1993; Schott et al., 2006). Only activation
differences that showed non-overlapping conﬁdence intervals for
Pro homozygotes and Leu carriers were considered reliable.
To testwhether geneticallymediatedACCactivation differences
were associated with performance differences on the behavioral
level, we computed a stepwise linear regression analysis with ACC
activation in the high interference condition (emotional vs. neu-
tral incongruent) as dependent variable and the RTs in the four
conditions (incongruent vs. congruent× emotional vs. neutral) as
independent variables.
IMMUNOHISTOCHEMISTRY AND WESTERN BLOTTING
Human brain material
Brain material was obtained from the New Magdeburg Collec-
tion (Department of Psychiatry and Psychotherapy, University
Hospital Magdeburg, Germany). The collection of human brain
material has been carried out in accordance with German laws
and the rules outlined by the local ethics committee. Brains from
four individuals (one 50-year-old female and three males of age
48, 54, and 56 years) without any signs of neurological or psy-
chiatric disorders were studied. The postmortem intervals ranged
from 11 to 24 h. Two brains were ﬂash–frozen in liquid nitrogen
for biochemical purposes, and the other two were processed for
immunohistochemistry.
Immunohistochemical procedures
Brain tissue was processed for histochemical analyses in a standard
manner, including immersion ﬁxation in 8% phosphate-buffered
formaldehyde for 2months, embedding in paraplast, and cut-
ting with a microtome (whole brain sections, 20μm). Every 50th
section was histologically stained by combining the methods of
Nissl and Heidenhain–Woelcke. To localize AKAP5 immunore-
activity, we used a commercially available mouse monoclonal
antibody raised against the human AKAP79 protein (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). The working dilution of
the primary antiserum was 1:100 in PBS. The nickel-enhanced
avidin–biotin technique was used as described previously (Bern-
stein et al., 1999). The speciﬁcity of immunoreactivity was con-
trolled by replacing the antibody with buffer and Ig-free serum.
Brain regions were selected for AKAP staining based on the results
of our fMRI study.
Western blotting
Protein preparation and Western blotting were essentially per-
formed as described previously (Seidenbecher et al., 2002; Schott
et al., 2006),with minor modiﬁcations. Brieﬂy, human brain tissue
from the hippocampus (including dentate gyrus andCA1 andCA3
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regions), the cingulate cortex and from the cerebellumwashomog-
enized in 20mM HEPES (pH 7.4) containing 20mM NaCl, 5mM
EDTA, and 1% Triton X-100 and centrifuged at 20.000× g for
30min. Protein probes from the pellet and supernatant were sol-
ubilized with SDS and mercaptoethanol. Proteins were separated
by SDS-PAGE on 5–20% gels under fully reducing conditions,
and transfer onto nitrocellulose was performed according to stan-
dard protocols. Western blots were incubated overnight with the
primary antibody also used for immunohistochemistry and devel-
oped using the enhanced chemiluminescence detection system
(Amersham, Arlington Heights, IL, USA).
RESULTS
EFFECTS OF AKAP5 PRO100LEU ON HUMAN AGGRESSION AND ANGER
To assess a potential inﬂuence of AKAP5 Pro100Leu on human
aggression and anger, we systematically investigated genotype-
dependent group differences in well-established self-report ques-
tionnaires of aggressive behavior and anger expression in a cohort
recruited from the interdisciplinary campus community of the
University of Magdeburg, Germany. From 527 young, healthy
participants (289 women, 238 men), complete genetic, and ques-
tionnaire data were available. In this cohort, we identiﬁed 370
Pro homozygotes, 150 heterozygotes, and 7 Leu homozygotes.
With 15.6% frequency of the Leu allele and 28% heterozygosity,
the distribution was at Hardy–Weinberg equilibrium (X 2 = 3.646;
p = 0.162), and frequencies were similar to those observed pre-
viously in a Caucasian population (Frank et al., 2008). Detailed
demographics are shown in Table 1. To avoid population strat-
iﬁcation effects, participants were also genotyped for additional
polymorphisms in unrelated genes (see Materials and Methods).
The polymorphisms were observed at allele frequencies similar
to those reported previously, and no imbalance was observed
in the distribution of any of these polymorphisms between Pro
homozygotes and Leu carriers (all p> 0.133). However, the distri-
bution varied between male and female participants, with the Leu
allele being signiﬁcantly more prevalent in females (X 2 = 9.37;
p = 0.009; Figure 1D; see supplemental information for discus-
sion). Given the low number of Leu homozygous subjects (n = 7),
all Leu carriers (Pro/Leu and Leu/Leu) were grouped together for
all further analyzes.
Buss–Perry aggression questionnaire and STAXI results are
displayed in Figure 2 (see also Table 2), separated by AKAP5
genotype. Because of the unequal distribution of AKAP5
Pro100Leu across gender and because of a small age differ-
ence between genotypes (Table 1), we computed a MANOVA
with gender and AKAP5 genotype as independent factors and
age as covariate. Dependent variables were the four dimen-
sions of the BPAQ and all STAXI domains except for state
Table 1 | Demographic data of the behavioral study.
Pro/Pro Pro/Leu, Leu/Leu
W/M 191/179 98/59 X 2 =9.37; p =0.009*
Age 23.1±3.1 22.4±2.9 t =2.19; p =0.029*
W/M, women/men. Mean age and SD are shown.
FIGURE 2 | Effects of AKAP5 Pro100Leu on aggression and anger.Top: in
the BPAQ, AKAP5 Pro100Leu was associated with signiﬁcantly lower
physical aggression in Leu carriers. Bottom AKAP5 Pro100Leu also
predicted higher STAXI anger control scores in Leu carriers. Bar plots depict
mean test scores±SE, separated by AKAP5 genotype.
anger. The MANOVA yielded main effects of AKAP5 genotype
and gender, but no signiﬁcant interaction (Table 2, bottom).
There was also a signiﬁcant main effect of age (see below).
Between-subjects univariate ANOVAs yielded signiﬁcant effects
of AKAP5 genotype on the physical aggression scale of the BPAQ
(F1,522 = 8.087; p = 0.005; η2 = 0.015) and on the anger con-
trol scale of the STAXI (F1,522 = 6.917; p = 0.009; η2 = 0.013).
Post hoc one-tailed two-sample t -tests showed that AKAP5
Leu carriers had signiﬁcantly lower scores in physical aggres-
sion (t 525 = 2.874; p = 0.004, Bonferroni-corrected) and signif-
icantly higher scores in anger control (t 530 = 2.354; p = 0.019,
Bonferroni-corrected).
To test, which of the dependent variables distinguished best
between AKAP5 Pro homozygotes and Leu carriers, the four
domains of interest from the BPAQ (physical aggression, ver-
bal aggression, anger, hostility) and the STAXI scales for trait
anger, anger-in, anger–out, and anger control were entered into
a stepwise LDA. The LDA showed that physical aggression (Wilk’s
lambda= 0.985; F1,1,525 = 8.262; p = 0.004) and anger control
(Wilk’s lambda= 0.975; F2,1,524 = 6.687; p = 0.001) separated the
two genotype groups best, with no other subscores of either
questionnaire entering the model.
In order to validate our results obtained in the German
cohort we performed post hoc genotyping for AKAP5 Pro100Leu
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in a previously described cohort of 604 participants from the
University of Barcelona community (457 female, mean age
21.6± 3.1 years; see Krämer et al., 2007, for detailed demo-
graphics). The participants had completed the Spanish version
of the BPAQ, but no STAXI scores data were available from
that cohort. Table 3 displays demographic data and BPAQ
scores. Carriers of the Leu allele showed trends for lower total
BPAQ scores (t = 1.515; p = 0.065, one-tailed) as well as for the
domains physical aggression (t = 1.478; p = 0.073, one-tailed),
hostility (t = 1.666; p = 0.048, one-tailed), and, to a lesser degree,
anger (t = 1.128, p = 0.130, one-tailed). These trends could be
observed across the whole group and in female participants
alone.
GENDER AND AGE EFFECTS ON BPAQ AND STAXI SCORES
While age and gender did affect BPAQ and STAXI scores, they
exerted their inﬂuence on domains distinct from those affected by
AKAP5 Pro100Leu genotype. In our MANOVA model, a signiﬁ-
cant gender effect was observed for the anger-out dimension of the
STAXI (F1,522 = 4.292; p = 0.039; η2 = 0.008), but not for either
physical aggression or anger control (all p> 0.523). At the level
of between-subject comparisons, we also observed a signiﬁcant
genotype by gender interaction for anger control (F1,522 = 6.740;
p = 0.010; η2 = 0.013). Age exerted a signiﬁcant effect on the
trait anger dimension of the STAXI (F1,529 = 10.051; p = 0.002;
η2 = 0.019), but there were no age effects on either physical or
verbal aggression or on anger control (all p> 0.131). Post hoc
Pearson correlations showed a weak but signiﬁcant negative cor-
relation between age and trait anger (r =−0.121; p = 0.005) and
a trend for a negative correlation between age and the anger-out
scale (r =−0.084; p = 0.053). No further signiﬁcant correlations
between age and BPAQ or STAXI subscores were observed (all
p> 0.203).
EFFECTS OF AKAP5 PRO100LEU ON NEURAL CORRELATES OF
EMOTIONAL INTERFERENCE
To further explore the neural mechanisms that might underlie the
observed associations of AKAP5 Pro100Leu with aggression and
anger control, we conducted an fMRI study in 67 young, healthy
participants (34 Pro homozygotes, 33 Leu carriers). Because of
the observed effect of AKAP5 Pro100Leu on anger control and
the known trait anger-related attentional bias for angry faces (Van
Honk et al., 2001),we hypothesized that Pro homozygotes and Leu
carriers might differ at neural level during the cognitive control
of emotional interference. We addressed this hypothesis by using
an Erikson ﬂanker paradigm with task-irrelevant background pic-
tures (Larson et al., 2006; Wiswede et al., 2009), which, in our
study, were angry vs. neutral faces (Figure 3A). In the Eriksen
ﬂanker paradigm, processing of incongruent stimuli is typically
associated with activations in medial frontal cortex (mFC) regions
like the supplementary motor area (SMA, Brodmann area/BA 6)
and the ACC (Ridderinkhof et al., 2004).
Table 3 | Demographic data and mean BPAQ scores of Spanish cohort.
Pro/Pro Pro/Leu, Leu/Leu
W/M 316/109 141/38
Mean age 21.7±3.2 21.3±2.8
Total BPAQ 65.1±15.4 63.2±13.1
Physical aggression 15.5±5.3 14.9±4.8
Verbal aggression 13.1±3.9 13.1±3.3
Anger 17.5±5.4 17.1±4.7
Hostility 18.9±5.5 18.1±4.9
W/M, women/men.
Table 2 | Effects of AKAP5 Pro100Leu on BPAQ and STAXI scores.
BPAQ STAXI
Physical aggression Verbal aggression Anger Hostility Trait anger Anger-in Anger-out Anger control
Pro
W 17.6±5.84 14.7±2.71 18.7±4.67 21.2±4.60 4.8±2.23 5.8±1.62 5.4±1.99 4.8±1.41
M 17.3±5.94 14.6±2.60 18.0±4.70 21.0±4.27 5.0±2.29 5.6±1.87 5.8±1.88 4.3±1.77
Leu
W 15.8±5.16 14.3±2.65 18.3±4.15 21.1±5.18 4.6±2.31 5.6±1.81 5.3±2.15 4.8±1.70
M 16.1±4.95 14.3±2.80 17.4±4.28 21.8±4.25 4.9±2.34 5.9±1.73 5.5±2.05 5.1±1.56
AKAP5 GENDER AKAP5×GENDER AGE
Wilk’s λ 0.966 0.960 0.983 0.970
F 8,515 2.260 2.653 1.093 2.022
p 0.022* 0.007* 0.367 0.042*
η2 0.034 0.030 0.017 0.034
Top: test scores separated by gender and AKAP5 genotype (means and SD are shown). BPAQ, Buss–Perry aggression questionnaire; STAXI, state-trait anger expres-
sion inventory; Pro, 100Proline carriers; Leu, 100Leucine carriers;W, women; M, men. Bottom: results of the MANOVA (ﬁxed factors: AKAP5; gender; covariate: age),
*p<0.05.
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FIGURE 3 | Functional MRI correlates of emotional interference. (A)
Schematic illustration of the experimental paradigm in Section “Materials
and Methods” for details. (Note: the example face stimuli in this ﬁgure
and Figure 4 are not part of the actual stimulus set used in the
experiment, but were created by the authors for illustrative purposes.) (B)
Leu carriers exhibited increased activation of the ACC (BA 24, extending
into BA 6) for emotional vs. neutral background pictures in the
incongruent condition, when compared to Pro homozygotes. Conversely,
Pro homozygotes showed higher activation of the medial OFC. All
activations were signiﬁcant at p<0.05, small-volume FWE-corrected for
anatomical ROIs. Coordinates are in MNI space; box plots depict ﬁtted
and adjusted responses for emotional vs. neutral backgrounds in the
incongruent condition, separated by genotypes; error bars depict
conﬁdence intervals obtained from Bootstrap resampling.
Behavioral results
Demographic and behavioral data of the fMRI study are
summarized in Table 4. Error rates were signiﬁcantly higher
in the incongruent relative to the congruent ﬂanker con-
dition (main effect of congruency: F1,65 = 42.56; p< 0.001;
two-way ANOVA for repeated measures with AKAP5 geno-
type as between-subjects factor). There were also slightly
higher error rates in the emotional vs. neutral conditions
(F1,65 = 4.33; p = 0.041), but no signiﬁcant interaction between
congruency and emotional vs. neutral background pictures
(F1,65 = 2.42; p = 0.125). Post hoc one-tailed t -tests suggested
that the effects of emotionality on error rates were mainly dri-
ven by the incongruent condition (incongruent: T 66 = 1.892;
p = 0.032; congruent: T 66 = 1.097; p = 0.139). AKAP5 geno-
type did not inﬂuence error rates in any condition (all
p> 0.314).
Reaction times were signiﬁcantly longer in the incongruent
relative to the congruent condition (F1,65 = 226.22; p< 0.001;
two-way ANOVA for repeated measures with AKAP5 genotype
as between-subjects factor), but there was no effect of emotional
background on RTs and no interaction between congruency and
emotion (all p> 0.488). A nominal tendency for shorter RTs in
Leu carriers relative to Pro homozygotes in all conditions was not
signiﬁcant (main effect of AKAP5 and all interactions withAKAP5
genotype: all p> 0.246).
Functional MRI results
T -test based ROI analyses comparing the emotional vs. neutral
contrasts in the incongruent condition revealed that AKAP5 Leu
carriers showed a signiﬁcantly stronger emotion-dependent acti-
vation of a cluster within the left (ACC, BA 24, extending into the
supplementary motor area, SMA, BA 6; p = 0.019, FWE-corrected
forROI volume)when compared to Pro homozygotes (Figure 3B).
This activation difference showed non-overlapping 95% conﬁ-
dence intervals for Pro homozygotes and Leu carriers as estimated
using Bootstrap resampling and the percentile-t method (Efron
and Tibshirani, 1993; Schott et al., 2006). We also observed a ten-
dency for increased emotion-dependent activation of the right
ACC [BA 32; (x y z)= (12 35 28)] in Leu carriers during incongru-
ent trials, but this activation difference showed only a trend after
small-volume FWE correction (p = 0.071, FWE-corrected for ROI
volume).
Pro homozygotes, on the other hand showed relatively
increased activity in the right medial OFC during incongruent
emotional trials when compared to Leu carriers. The activa-
tion difference in the OFC was signiﬁcant after small-volume
FWE correction (p = 0.003, FWE-corrected for ROI volume), and
Bootstrap-based95%conﬁdence intervals didnot overlapbetween
Pro homozygotes and Leu carriers.
In the congruent condition, the pattern observed in the incon-
gruent condition was partly reversed. Here, Pro homozygotes
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Table 4 | Demographic and behavioral data of the fMRI experiment.
Pro/Pro Pro/Leu, Leu/Leu
W M W M
N 18 16 19 14 X 2 =0.002; p =0.888
Mean age 24.1±2.9 25.4±2.0 23.9±2.0 25.6±4.2 F =0.01; p =0.972
Error rates
Incongruent
Emotional 3.18+4.76 3.94±4.87
Neutral 2.85±3.95 3.18±3.85
Congruent
Emotional 0.26±0.83 0.27±0.63
Neutral 0.26±0.71 0.09±0.38
RTs (ms)
Incongruent
Emotional 594±106.7 570±111.6
Neutral 597±105.6 569±113.5
Congruent
Emotional 494±64.1 470±72.3
Neutral 494±63.4 471±73.0
Mean error rates and reaction times±SD are shown. RT, reaction time; W/M, women/men.
showed a stronger ACC activation relative to Leu carriers [BA24;
(x y z)=(−15 −4 49); p = 0.048, FWE-corrected for ROI vol-
ume], and this activation difference was robust after bootstrap
resampling. No FWE-correctable genotype-related activation dif-
ferences in either direction were observed in the OFC during the
congruent condition.
Brain-behavior correlations
Across our study cohort, we observed a negative correlation of
RTs with emotion-related ACC activation peak in the incongruent
condition. A stepwisemultiple regression analysis showed that this
RT advantage was most prominent in the emotional incongruent
condition itself (β=−0.258; p = 0.035). Neither OFC activation
differences during the incongruent condition and the peak activa-
tion difference in theACCduring the congruent condition showed
a correlation with RTs, and neither ACC nor OFC activations
were signiﬁcantly correlated with error rates in any condition (all
p> 0.1).
EXPRESSION OF AKAP5 IN HUMAN FRONTOLIMBIC CORTICES
Previous studies had demonstrated AKAP5 expression in the
human amygdala, hippocampus and striatum, but no information
was thus far available on the expression of AKAP5 in frontolim-
bic cortical structures. In our experiments AKAP5 Pro100Leu
affected cortical rather than subcortical limbic activity during
emotional interference. Therefore, expression of AKAP5 in the
human frontal limbic neocortex was taken into account. We used
immunohistochemistry on post mortem human brain tissue to
assess expression of AKAP5 in human anterior cingulate, medial
frontal, and orbitofrontal regions, based on our fMRI results.
Indeed, we found AKAP5 immunoreactivity widely distributed
in the human cortex. In the ACC (BA 24, 32) and in the mFC
(BA 6) AKAP5 was expressed in pyramidal cells and a subset of
interneurons (Figure 4A, top row, middle row, left). A similar
expression pattern was observed in the medial OFC (BA 11). To
verify the validity of these ﬁndings, AKAP5 immunoreactivity was
also assessed in the hippocampus and striatum, brain regions that
have previously been shown to express AKAP5 (Sik et al., 2000;
Ulﬁg et al., 2001; Figure 4A, bottom row). Western blotting using
the same primary antibody revealed expression of the previously
observed AKAP5-immunoreactive band at approximately 75 kDa
(Gardner et al., 2006) in the detergent-insoluble pellet fractions
of the human hippocampus and cingulate cortex (Figure 4B), but
not in the cerebellum, compatible with previous observations for
the AKAP5 ortholog in rodents (Ostroveanu et al., 2007), thus
conﬁrming the speciﬁcity of the antibody.
DISCUSSION
In our study cohort of 527 young, healthy participants, the AKAP5
Pro100Leu polymorphism was associated with human aggression
and anger traits. Speciﬁcally, carriers of the less common Leu allele
showed lower physical aggression and higher anger control relative
to Pro homozygotes. In line with the behavioral data, Leu carriers
exhibited stronger activations in the left ACC (BA 24) in our fMRI
study of emotional interference. Complementary, Pro homozy-
gotes showed a stronger activation in the right medial OFC during
the same experimental condition.
AKAP5 AND THE GENETIC VARIABILITY OF AGGRESSION AND ANGER
Previous studies on genetically mediated variability of aggres-
sion and anger have largely focused on genes directly related to
neuromodulatory, particularly monoaminergic, transmitter sys-
tems (Buckholtz and Meyer-Lindenberg, 2008; Kang et al., 2008;
Kulikova et al., 2008; Hess et al., 2009). Here we could demon-
strate that a genetic variation in an adaptor molecule that is
involved most likely in intracellular signaling pathways of sev-
eral monoaminergic neurotransmitter systems is associated with
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FIGURE 4 | Expression of AKAP5 in the human medial frontal cortex.
(A)Top, middle row: strong AKAP5 immunoreactivity was observed in
pyramidal cells and a subset of interneurons in the medial anterior cingulate
(BA 24, 32) and in the medial PFC/supplementary motor area (SMA, BA 6).
A similar pattern was also observed in the orbitofrontal cortex (OFC, BA 11).
Bottom row: positive control staining from the hippocampus and striatum
conﬁrm previous ﬁndings. (B)Western blotting conﬁrmed AKAP5
immunoreactivity in a ∼75 kDa band in the pellet fractions of the
hippocampus and in the cingulate cortex, but not in the cerebellum.
human anger and aggression phenotypes in young, healthy, par-
ticipants. Notably, carriers of the less common variant show
lower aggression and stronger anger control when compared to
homozygotes of the presumedwild type allele. The associationwas
observed in young, healthy participants and is therefore likely to
reﬂect variability in the normal population. It should be noted that
effect sizes were small, but given the complexity of both the pheno-
types and themultiple other genetic and environmental inﬂuences,
no larger inﬂuence could have been reasonably expected. In our
analysis, effects of AKAP5 Pro100Leu were primarily observed for
the dimensions of physical aggression and anger control, while
other BPAQ and STAXI subscales showed trends into the same
direction that did not reach signiﬁcance.
The AKAP5 gene product interacts with beta-adrenergic recep-
tors (Gardner et al., 2006), which are highly expressed in
the mammalian brain. As beta-adrenergic signaling has been
associated with human aggression (Fava, 1997; Hess et al., 2009),
modulation of CNS beta-adrenergic activity might be a promis-
ing explanation for our observations. AKAP5 has also been linked
to dopaminergic signaling and its interaction with glutamatergic
neurotransmission (Swayze et al., 2004). Among the neuromodu-
latory monoamines, serotonin has previously been particularly
strongly linked to aggressive behavior (Buckholtz and Meyer-
Lindenberg, 2008; Popova, 2008). The role of AKAP5 in serotoner-
gic signaling is thus far unclear, however, an in vitro study suggests
a molecular association of AKAP150 with different 5HT receptors
(Sandoz et al., 2006). Investigating a potential role of AKAP5 in
the serotonergic system is therefore warranted to help explain the
present results.
Because our study cohort consisted mainly of students, one
might argue that it was somewhat stratiﬁed. It should be noted,
though, that students were from a large variety of ﬁelds of stud-
ies (including economics, educational and natural sciences, and
medicine, among others), and that the distribution of numer-
ous additional genetic polymorphisms, which all occurred with
the previously reported allele frequencies, showed no signiﬁcant
linkage disequilibrium with AKAP5 Pro100Leu. Moreover, the
observation of a behavioral phenotype related to a genetic varia-
tion in a socially rather homogeneous population, such as the one
investigated here,would be expected to be rather subtle and thus, if
detected, even more likely to result from genetic differences rather
than a sampling bias. Despite a small difference in the distribu-
tion of AKAP5 Pro100Leu between men and women (see Results),
multivariate statistics revealed independent main effects of gender
and genotype that were observed for distinct subscales.
Further though limited support for the validity of the present
results comes from post hoc analysis of AKAP5 Pro100Leu on
BPAQ scores in a previously reported cohort from Barcelona
(Krämer et al., 2007), where comparable trends for lower aggres-
sion in Leu carriers were observed. Although the investigation of
theAKAPpolymorphism and its link to human aggressionwas not
the primary goal in the original design of the Barcelona cohort, it
yielded comparable trends for lower aggression in Leu carriers, but
the effects were generally less pronounced and did not reach sta-
tistical signiﬁcance in two-tailed comparisons. However, it should
be noted that the participants from the Spanish cohort had overall
lower BPAQ scores those from the German cohort. The most likely
explanation for this might be that the majority of participants in
the Spanish studywere female (75.6%), andwomen showed gener-
ally lower aggression. Furthermore, the lower overall BPAQ scores
might also be related to linguistic or cultural aspects of the Spanish
BPAQ version, as in an earlier validation study, García-León et al.
(2002) had also reported lower scores in their Spanish subjects
as compared Buss and Perry’s original validation of the question-
naire in an American sample, and a direct comparison of BPAQ
scores with Dutch and Japanese samples also revealed lower BPAQ
scores in a Spanish cohort (Ramírez et al., 2001). The sensitivity
of the BPAQ might also have been reduced to some degree by
the fact that the participants from Barcelona were largely native
speakers of Catalán rather than Spanish, but the Spanish version
of the questionnaire was used. Support for the notion that the
BPAQ might show linguistically or culturally mediated differences
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in sensitivity comes from several studies on adaptations of the
BPAQ in different languages and cultures (Meesters et al., 1996;
Nakano, 2001; Fossati et al., 2003). Those studies were able to
conﬁrm the four-factor structure, but reported disagreements on
item level and concerning the interpretation of the factors (Von
Collani and Werner, 2005), which might be reﬂected here by hos-
tility being the BPAQ factor most strongly associated with AKAP5
Pro100Leu in the Spanish, but not in the German cohort. Future
attempts to replicate our results in different ethnic and cultural
populations should therefore include additional instruments, par-
ticularly the STAXI, which had not been obtained in the Barcelona
cohort.
In the present study, we had focused our investigations on
aggression and anger traits. It should be noted, however, that
we cannot exclude further inﬂuences of the polymorphism on
individual differences in emotional processing beyond aggression
and anger. Previous animal research has demonstrated a role for
AKAP5 in anxiety and fear memory (Moita et al., 2002; Nijholt
et al., 2008; Tunquist et al., 2008). Further research is required
to assess potential effects of AKAP5 Pro100Leu on anxiety and
possibly on the processing of other negative emotions.
AKAP5 PRO100LEU AND ITS EFFECT ON THE PROCESSING OF
EMOTIONAL INTERFERENCE
Compatible with signiﬁcantly higher anger control in Leu car-
riers, our fMRI study showed stronger activation of the left
(ACC, BA 24) in Leu carriers relative to Pro homozygotes when
an angry face was presented in the background of an incon-
gruent trial, that is, when emotional interference occurred in
the condition that required higher attentional control. Increased
activation of brain regions involved in attention and executive
functions has previously been linked to decreased processing efﬁ-
ciency (Egan et al., 2001; Blasi et al., 2005; Meyer-Lindenberg
and Weinberger, 2006). In those studies, increased prefrontal or
ACC activation occurred despite similar or even inferior behav-
ioral performance. Here we observed a signiﬁcant correlation
between the ACC BOLD signal in the emotional incongruent
condition and shorter RTs. Moreover, as error rates did not sig-
niﬁcantly covary with the ACC response and were not higher
in Leu carriers relative to Pro homozygotes, the reduced RTs
likely reﬂect an actual behavioral advantage rather than impul-
sivity or a behavioral tradeoff, which would be associated with
a corresponding error rate increase (Caldu et al., 2007). Com-
patible with our results, a recent study investigating the role
of the well-described catechol-O-methyl transferase (COMT)
Val108/158Met polymorphism on inhibitory control of mem-
ory has shown a similar pattern of increased cortical activity
linked to better task performance. In that study, COMT Met
carriers showed increased prefrontal activation during selective
retrieval associated with more efﬁcient inhibition of irrelevant
memories (Wimber et al., 2011). Also, the observation that genet-
ically mediated differences in brain activity predicted RTs more
accurately than a direct comparison of the different allele car-
riers (see Results) is compatible with previous studies in which,
similarly, fMRI correlates of cognitive processes showed correla-
tions with both genetic variations and behavior that were stronger
than the direct relationship between the respective genotypes and
behavioral phenotypes (Bertolino et al., 2006; Forbes et al., 2009).
For the commonly investigated COMT Val108/158Met polymor-
phism,ameta-analysis further demonstrated thatBOLDresponses
are more sensitive to genetic modiﬁers as compared to direct
behavioral measures, and the authors suggested that the fMRI
endophenotype might reﬂect a neural mediator of pleiotropic
effects of genetic variations on complex human behavior (Mier
et al., 2010).
Given the observed relationship between increased ACC acti-
vation and shorter RTs, our results are in line with previously
reported anger-related attentional biases for angry faces (Van
Honk et al., 2001). While the ACC activation was found to be
higher in Leu carriers, we observed a reverse effect in the right
medial OFC, where Pro homozygotes exhibited a stronger fMRI
response in the emotional incongruent condition, that is, in
the same experimental condition where Leu carriers show their
increased ACC activity. Moreover, activation of the ACC was
observed in Pro homozygotes during emotional interference in
the congruent condition. This activation might indeed reﬂect inef-
ﬁcient recruitment of the ACC as it was not correlated with a
behavioral advantage during task performance.
Notably, these activation patterns reﬂect the previously pro-
posed differentiation of a ventral affective processing system
(VAPS) and a dorsal executive control system (DECS; Dolcos
and Mccarthy, 2006). It is supposed that emotionally salient
stimuli are processed in VAPS regions like the amygdala and
the OFC while executive functions recruits DECS regions like
the dorsolateral prefrontal cortex (DLPFC), posterior parietal
cortex, and ACC (Pessoa, 2008; Hart et al., 2010). Related to
our ﬁndings we suggest that Leu carriers, who exhibit higher
anger control and a stronger ACC activation in the emotional
incongruent ﬂanker condition, emphasize the requested executive
control during task performance. Pro homozygotes, in contrast,
might react more sensitively to the emotional (angry) back-
ground stimuli, as reﬂected by a lower anger control and stronger
activation of the VAPS in the emotional incongruent ﬂanker
condition.
Additionally, in order to test whether the observed effects of
AKAP5 on emotional interference processing in the ACC and the
OFC might reﬂect a local phenomenon related to monoaminer-
gic modulation of ACC and OFC activity or rather the result of
large-scale network activity, we had investigated the expression
of AKAP5 in post mortem human brain tissue. Since AKAP5 was
detected in both ACC and OFC pyramidal cells and interneurons
(Figure 4), a locally mediated effect of AKAP5 on cognitive con-
trol of anger and aggression is possible, however, a more indirect
mechanism, for example by inﬂuencing amygdala-dependent pro-
cessing of anger, cannot be excluded.Although themean age of the
donors in the post mortem investigations (52.0 years) was substan-
tially higher than that of the participants in the questionnaire and
fMRI studies (22.9 years), it should be noted that mRNA proﬁling
in younger donors (24 and 39 years, respectively) has also provided
evidence for AKAP5 expression in frontolimbic structures (Allen’s
Brain Atlas1).
1http://human.brain-map.org
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POTENTIAL MOLECULAR CONSEQUENCES OF AKAP5 PRO100LEU
An important direction for future researchwill be the investigation
of molecular consequences of AKAP5 Pro100Leu. The polymor-
phism is located close to the second basic membrane localization
domain and the GPCR-binding region (Figure 1A) and affects
the length of an alpha-helical structure and the geometry of the
membrane-attached N-terminus (Figure 1B), with a potential
effect on the folding of the downstream domains (Protein folding
was predicted using the PEP-FOLD prediction software2).
Given the localization of the polymorphism within the AKAP5
gene, we tentatively suggest that Pro100Leu might modulate
interactions with GPCRs. The consequences of such an interac-
tion are, however, be difﬁcult to predict, particularly in relation
to a complex behavioral phenotype such as aggression. AKAP5
Pro100Leu might, for example, affect the colocalization of GPCRs
with their intracellular targets. Apart from a potential inﬂuence
of AKAP5 interaction with GPCRs, it appears also plausible that
the polymorphism might affect the interactions of AKAP5 with
other post-synaptic adaptor molecules or with the post-synaptic
membrane.
CLINICAL IMPLICATIONS
AKAP5 Pro100Leu has rarely been investigated thus far in clini-
cal association studies, with only one published study in oncol-
ogy, yielding a negative result (Frank et al., 2008). While AKAP5
Pro100Leu has not been investigated in the context of neurological
or psychiatric disorders, a previous study suggested aberrant gene
number variations of AKAP5 in schizophrenia and bipolar disor-
der (Wilson et al., 2006), althoughdata are yet inconsistent (Sutrala
et al., 2007). Given the high prevalence of aggressive behavior
2http://bioserv.rpbs.univ-paris-diderot.fr/PEP-FOLD/
and impaired impulse control in psychiatric disorders, our results
suggestAKAP5an interesting candidate gene for future researchon
risk factors for neuropsychiatric diseases associated with aggres-
sion or impulsivity.We tentatively suggest that the Leu allele might
confer a protective effect.
CONCLUSION
By using a multimodal approach including behavioral genetics,
fMRI and post mortem immunohistochemistry, we could demon-
strate that AKAP5 Pro100Leu is associated with human aggression
and anger, with the Leu allele conferring a less aggressive pheno-
type with higher anger control. The fMRI results further suggest
that individual differences in frontolimbic processing of emo-
tional interference might constitute a neural basis of the higher
anger control in Leu carriers. This is supported by immunohis-
tochemical demonstration of AKAP5 expression in frontolimbic
cortices. Our results indicate that future research on genetic mech-
anisms of aggression and anger should include intracellular sig-
naling and adaptor proteins instead of only focusing on molecules
directly involved in neuromodulatory transmission. Furthermore,
our results suggest AKAP5 as a novel potential candidate gene for
psychiatric disorders with altered aggression or impulse control.
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